GrantRover ↗

← Alle Förderungen

Horizon Europe · Europäische Union

Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

Öffnet am 10. Februar 2027

Das EU-Programm Horizon Europe plant 1 Förderungen mit 3 Mio. € pro Projekt bei einem Gesamtbudget von 3 Mio. €. Die Einreichungsfrist endet am 16. September 2027 (EU-Ausschreibungen enden meist um 17:00 Uhr Brüsseler Zeit). Organisationen aus EU-Mitgliedstaaten und assoziierten Ländern wie der Türkei können in der Regel teilnehmen; maßgeblich sind die Bedingungen des Topics.

Frist
16. September 2027 (in 305 Tagen)
Öffnet
10. Februar 2027
Fördersumme
3 Mio. € pro Projekt
Förderquote
100 % der förderfähigen Kosten Standardregel des Programms; die Ausschreibung kann abweichen.
Gesamtbudget
3 Mio. €
Erwartete Förderungen
1
Maßnahmentyp
HORIZON Coordination and Support Actions · HORIZON Lump Sum Grant
Wahrscheinliche Antragstellende
Unternehmen, KMU / Start-ups, Gemeinnützige, Hochschulen & Forschung, Öffentliche Stellen Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Fördergeber
Horizon Europe (HORIZON)
Referenz
HORIZON-MISS-2027-02-CANCER-06
Ausschreibung
HORIZON-MISS-2027-02
Zuletzt geprüft
14. November 2026

Offizielle Ausschreibung öffnen ↗ Frist zum Kalender hinzufügen

Die offiziellen Beschreibungen sind in der Sprache des Fördergebers (meist Englisch); Zusammenfassung und Eckdaten auf dieser Seite sind auf Deutsch.

Erwartete Ergebnisse

This action supports the follow-up to the July 2023 Communication on EU Missions assessment [1] . The successful proposal under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:

• Together, a network of registered cancer charities and funding agencies support transnational research and innovation projects on quality of life of children (age range 0-14, age at time of first diagnosis), adolescents (age range 15-19, age at time of first diagnosis) and young adults (age range 20-39, age at time of first diagnosis), cancer patients and survivors using their own financial resources.

• Projects supported by the network of charities and funding agencies will boost quality of life and long-term outcomes for young cancer patients and survivors, including improved physical, emotional, and social well-being.

• Researchers, innovators, and professionals from different disciplines and sectors ensure accessibility and re-usability of relevant digital data, to support the future UNCAN.eu research data platform, which is currently in preparation.

Umfang

Due to significant investments in research and innovation, cancer survival rates in Europe have soared, with more than 12 million survivors, including 500,000 childhood cancer survivors. However, survivors, their families, and caregivers continue to face numerous challenges. Young cancer survivors, in particular, frequently suffer from long-term effects of treatment, including mental health issues like depression and anxiety, chronic pain, fatigue, cardiovascular complications, organ and skin changes, and infertility, all of which severely impact their quality of life.

Proposals should address all of the following:

• Together, registered cancer charities and funding agencies across EU Member States and Associated Countries, organise, fund and implement at least two transnational calls for proposals, resulting in grants to third parties to conduct research and innovation projects targeting quality of life of children (age range 0-14, age at time of first diagnosis), adolescents (age range 15-19, age at time of first diagnosis) and young adults (age range 20-39, age at time of first diagnosis) cancer patients and survivors. Grants should be awarded, not only in order of ranking but also to ensure that all three age groups are addressed.

Vollständigen Text lesen

• Organise regular networking activities between partners, as well as with representatives of successful projects, patients and patient organisations, citizens and stakeholders across EU Member States and Associated Countries to support the implementation of the action;

• Organise outreach campaigns at local, regional and national levels to raise awareness among different groups (citizens, patients and survivors, research communities, local, regional and national authorities etc.) about research and innovation projects funded through the transnational calls, including disseminating and exploiting research results. Where relevant, liaising with the National Cancer Mission Hubs which are in development through the ECHoS [2] project, should be considered.

Projects to be financed by charities and funding agencies through transnational calls for proposals are expected to:

• Develop, test and scale up in real-life settings innovative, holistic approaches and tools (including digital tools), optimising cancer treatment and follow-up regimens to improve the quality of life of young cancer patients and survivors.

• All datasets produced should be described with metadata records in the EU dataset catalogue of the European Health Data Space, while all tools and models should take advantage of current European research infrastructures, should follow the principles of open science and made available through the future UNCAN.eu platform.

• The chosen intervention(s) should be adapted to the specificities of the provision of care at local, regional, or national level, duly reflecting the diversity across EU Member States and Associated Countries.

• Projects should clearly benefit local communities of patients and survivors.

Under…

Wer kann sich bewerben?

A single organisation from an EU Member State or associated country can apply (Horizon Europe standard rule).

Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.

Themen

Child health Health inequalities Public health Quality of health care Rehabilitation Rights of the child National funders Philanthropy late-effects quality of life survivorship

Zeitplan

Single-stage call. Next deadline 2027-09-16. The portal states the exact cut-off time (EU calls usually close at 17:00 Brussels time).

So bewerben Sie sich

  1. Lesen Sie das vollständige Topic im Portal: erwartete Ergebnisse, Umfang, Maßnahmentyp und die Teilnahmebedingungen einschließlich Länder- oder Konsortialvorgaben.
  2. Registrieren Sie jede Partnerorganisation im EU Funding & Tenders Portal, um einen PIC zu erhalten.
  3. Verbundprojekte in Forschung und Innovation benötigen in der Regel mindestens drei unabhängige Partner aus drei verschiedenen EU-Mitgliedstaaten oder assoziierten Ländern. Prüfen Sie die Regel für dieses Topic.
  4. Bereiten Sie Teil A (Verwaltungsformulare und Budget im Portal) und Teil B (technische Beschreibung auf der offiziellen Vorlage für diesen Maßnahmentyp) vor.
  5. Reichen Sie vor dem Fristende am Stichtag im Portal ein. Verspätete Anträge werden nicht angenommen.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Read the topic conditions on the EU Funding & Tenders Portal for eligible countries, consortium requirements, budget and the application route.
Where applicants must be based
Read the topic conditions on the EU Funding & Tenders Portal for eligible countries, consortium requirements, budget and the application route.
Where to apply
Read the topic conditions on the EU Funding & Tenders Portal for eligible countries, consortium requirements, budget and the application route.

EU-Leitfaden zur Antragstellung lesen

Offizielle Quellen

Offizielle Ausschreibungsseite

Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 14. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.

Weitere Ausschreibungen: Horizon Europe

Horizon Europe Europäische Union

Neutral-Atom Platform Technologies

HORIZON-JU-EUROHPC-2026-NAPT-11-01

This action aims to establish European leadership in neutral-atom quantum simulation and digital quantum computing by delivering: • Fully programmable industry-ready quan…

Horizon Europe Europäische Union

Next-Generation QKD Systems

HORIZON-JU-EUROHPC-2026-NQKD-12-01

This action will strengthen Europe's strategic autonomy in quantum-secure communications by advancing core QKD technologies and integration capabilities. Expected results…

Horizon Europe Europäische Union

Quantum Experimental Pilot Lines for Quantum Technologies

HORIZON-JU-EUROHPC-2026-QEXP-14-01

This action will strengthen Europe's leadership and strategic autonomy in quantum technologies by advancing experimental pilot line capacities as a vital stepping stone t…

Horizon Europe Europäische Union

Quantum-Testing Infrastructure for Quantum Technologies

HORIZON-JU-EUROHPC-2026-QTI-13-01

This action will establish a pan-European open-access testing and experimentation infrastructure for quantum technologies, enabling systematic validation and certificatio…

Horizon Europe Europäische Union

Superconducting Platform Technologies

HORIZON-JU-EUROHPC-2026-SPT-10-01

This action will consolidate Europe’s position in superconducting quantum computing through: • Establishment of a full-stack superconducting quantum computer aiming at 1.…